Mobile

A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and...

Update Il y a 5 ans
Reference: EUCTR2008-002079-28

A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery from Middle Cerebral Artery Ischemic Stroke

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To compare the efficacy MK-0724 8 mg/kg/hr x 1 hr daily for 7 days to placebo in patients with middle cerebral artery ischemic stroke using the Day 90 Action Research Arm Test (ARAT) scores.

Inclusion criteria

  • Middle cerebral artery ischemic stroke

Links